Drug Trial Radar · NCT07654361
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Last checked: Nov 20, 2026Latest source record: Aug 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
3,600
Planned (sponsor's estimate)
Start
Jul 13, 2026
Primary completion
Sep 2028
Study completion Nov 2028
Sponsor
- Lead sponsor
- Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 17, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 79 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Study GSBR-1290-12 is a Phase 3 pivotal, multicenter, global, randomized, placebo-controlled, double-blind study to investigate the long-term efficacy, safety, and tolerability of 3 maintenance doses of aleniglipron once daily (QD) compared with placebo, when used in combination with a reduced-calorie diet and increased physical activity. All participants will be randomized to at least 76 weeks of treatment to evaluate the effects on long term body weight changes, tolerability, and safety. In addition, the study will compare the effects between aleniglipron and placebo on blood pressure (BP), lipid parameters, patient-reported outcomes.
Conditions
- Obesity
- Overweight
- Chronic Weight Management
Interventions
AleniglipronDrug
Drug: aleniglipron administered orally Drug
PlaceboDrug
Drug: placebo administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percent change in body weight from BaselineTime frame: Baseline and Week 76
Locations
71 sites in 1 country. Site status is shown where the registry gives one.
ACCOMPLISH-1 Research Site
Birmingham, Alabama · Not yet recruiting
ACCOMPLISH-1 Research Site
Birmingham, Alabama · Not yet recruiting
ACCOMPLISH-1 Research Site
Phoenix, Arizona · Not yet recruiting
ACCOMPLISH-1 Research Site
Sun City West, Arizona · Not yet recruiting
ACCOMPLISH-1 Research Site
Tucson, Arizona · Not yet recruiting
ACCOMPLISH-1 Research Site
Escondido, California · Not yet recruiting
ACCOMPLISH-1 Research Site
Gardena, California · Not yet recruiting
ACCOMPLISH-1 Research Site
La Jolla, California · Not yet recruiting
ACCOMPLISH-1 Research Site
Modesto, California · Not yet recruiting
ACCOMPLISH-1 Research Site
Rolling Hills Estates, California · Not yet recruiting
ACCOMPLISH-1 Research Site
San Diego, California · Not yet recruiting
ACCOMPLISH-1 Research Site
Clearwater, Florida · Recruiting
ACCOMPLISH-1 Research Site
Leesburg, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Miami, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Ocala, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Ocoee, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Pembroke, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Tampa, Florida · Not yet recruiting
ACCOMPLISH-1 Research Site
Buford, Georgia · Not yet recruiting
ACCOMPLISH-1 Research Site
Columbus, Georgia · Not yet recruiting
ACCOMPLISH-1 Research Site
Lawrenceville, Georgia · Not yet recruiting
ACCOMPLISH-1 Research Site
Union City, Georgia · Not yet recruiting
ACCOMPLISH-1 Research Site
Woodstock, Georgia · Not yet recruiting
ACCOMPLISH-1 Research Site
Honolulu, Hawaii · Recruiting
ACCOMPLISH-1 Research Site
Meridian, Idaho · Not yet recruiting
ACCOMPLISH-1 Research Site
Rexburg, Idaho · Not yet recruiting
ACCOMPLISH-1 Research Site
Chicago, Illinois · Not yet recruiting
ACCOMPLISH-1 Research Site
Iowa City, Iowa · Not yet recruiting
ACCOMPLISH-1 Research Site
Wichita, Kansas · Not yet recruiting
ACCOMPLISH-1 Research Site
Louisville, Kentucky · Not yet recruiting
ACCOMPLISH-1 Research Site
Baton Rouge, Louisiana · Not yet recruiting
ACCOMPLISH-1 Research Site
Silver Spring, Maryland · Recruiting
ACCOMPLISH-1 Research Site
Methuen, Massachusetts · Not yet recruiting
ACCOMPLISH-1 Research Site
Needham, Massachusetts · Not yet recruiting
ACCOMPLISH-1 Research Site
Ann Arbor, Michigan · Not yet recruiting
ACCOMPLISH-1 Research Site
Mankato, Minnesota · Recruiting
ACCOMPLISH-1 Research Site
Richfield, Minnesota · Recruiting
ACCOMPLISH-1 Research Site
Gulfport, Mississippi · Not yet recruiting
ACCOMPLISH-1 Research Site
Ridgeland, Mississippi · Not yet recruiting
ACCOMPLISH-1 Research Site
Chesterfield, Missouri · Not yet recruiting
Showing 40 of 71 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.